1 / 7

Pediatric Vaccine Market to exceed US$ 48 Billion by 2024

Access full Research:<br><br>https://www.renub.com/pediatric-vaccines-market-doses-immunization-cases-and-forecast-worldwide-analysis-166-p.php<br><br>As per Renub Research analysis Pediatric Vaccine Market is projected to exceed US$ 48 Billion by the year 2024. Increasing government and non-government funding for the development of new vaccines, along with raising awareness about the benefits of vaccination, is certainly expected to positively drive the market growth in the coming years. In order to cut the healthcare expenses, governments have been making continuous efforts to reduce the cost of patient immunization through various vaccination programs funded by government or non-government health authorities. For example; several countries have included Children Vaccination Programs, which offers vaccines to children who lack health insurance or one who cannot afford the cost of vaccination.<br>

renubresearch
Download Presentation

Pediatric Vaccine Market to exceed US$ 48 Billion by 2024

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease (Influenza, MMR, Pneumonia, Meningitis, Hepatitis, Tap, Hib, Polio, etc) & Companies Pediatric Vaccine Market Analyst View: Pediatric Vaccine Market is projected to exceed US$ 48 Billion by the year 2024. Report Title: Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease (Influenza, MMR, Pneumonia, Meningitis, Hepatitis, Tap, Hib, Polio, etc) & Companies Access Full Research: https://www.renub.com/pediatric-vaccines-market-doses-immunization- cases-and-forecast-worldwide-analysis-166-p.php Get Free Customization in this Report As per Renub Research analysis Pediatric Vaccine Market is projected to exceed US$ 48 Billion by the year 2024. Increasing government and non-government funding for the development of new vaccines, along with raising awareness about the benefits of vaccination, is certainly expected to positively drive the market growth in the coming years. In order to cut the healthcare expenses, governments have been making continuous efforts to reduce the cost of patient immunization through various vaccination programs funded by government or non- government health authorities. For example; several countries have included Children Vaccination Programs, which offers vaccines to children who lack health insurance or one who cannot afford the cost of vaccination. © Renub Research Page 1 of 7 www.renub.com

  2. Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease (Influenza, MMR, Pneumonia, Meningitis, Hepatitis, Tap, Hib, Polio, etc) & Companies Growing prevalence of chronic diseases is another major market driver, driving the market of infant (pediatric) vaccines. The immune system is not fully developed in infants, hence they are at a higher risk of contracting severe diseases and so, vaccination plays a significant role in their prevention. According to WHO; effective immunization activities have had a major impact on reducing measles deaths. It is found that measles vaccination prevented an estimated 20.4 million deaths across the globe. Global measles deaths have decreased by 84% from an estimated 550,100 in 2000 to 89,780 in 2016. Request a free sample copy of the report: https://www.renub.com/contactus.php Renub Research report titled “Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease [Influenza, MMR (Measles, Mumps, and Rubella), Pneumonia, Meningitis, Hepatitis, Tap (Diphtheria, Tetanus, Pertussis), Haemophilus influenzae type B (Hib), Polio, Rotavirus, Varicella, and Combination Vaccine], Companies (GlaxoSmithKline, Merck, Sanofi, Pfizer, & Others)” provides a complete analysis of Global Pediatric (Infants) Vaccine Market. By Disease - Pneumococcal Vaccine is likely to grow at Noteworthy Rate in the Forthcoming Years The report studies the market of the following vaccine: Influenza, MMR (Measles, Mumps, and Rubella), Pneumonia, Meningitis, Hepatitis, Tap (Diphtheria, Tetanus, Pertussis), Haemophilus influenzae type B (Hib), Polio, Rotavirus, Varicella, and Combination Vaccine. Pneumococcal and Combination Vaccines together hold the significant market share in pediatric (infants) vaccine market and is expected to continue so during the forecast period. Nearly 650 Million Vaccines Doses will be administered in Pediatrics (Infants) by the year 2024 As per our analysis; it is estimated that by the year 2024, the doses of vaccines administered will reach nearly 650 Million. The number of vaccine doses is expected to grow considerably during the forecast period due to growing awareness among the parents about the benefits of vaccines and also the developing countries around the world that now have included a number of vaccines to their national immunization programme as per WHO recommendations, which indeed will drive the pediatric vaccine market in recent years. Regional - Immunization Profile The report also comprises of the en-detail study of global and regional immunization profile: By Diseases such as Measles, Mumps, Rubella, Diphtheria, Tetanus, Polio and so on and By Regions such as Africa (AFR), Americas (AMR), Eastern Mediterranean (EMR), Europe (EUR), South-East Asia (SEAR), Western Pacific (WPR) and Global. Company Analysis GlaxoSmithKline, Merck, Sanofi, and Pfizer are some of the top companies that deal efficiently in vaccine business globally. These companies have been studied thoroughly in the report. © Renub Research Page 2 of 7 www.renub.com

  3. Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease (Influenza, MMR, Pneumonia, Meningitis, Hepatitis, Tap, Hib, Polio, etc) & Companies Global Pediatric (Infants) Vaccine Market has been extensively studied from 3 major points: 1. Pediatrics Vaccines (Disease wise) Market & Forecast 2. Number of Vaccinated Pediatric (Infants) (Disease wise) & Forecast 3. Doses of Vaccines Administered in Pediatric (Infants) (Disease wise) & Forecast Client can Purchase this Report in Sections from below link: Access full Research: https://www.renub.com/pediatric-vaccines-market-doses-immunization- cases-and-forecast-worldwide-analysis-166-p.php This market research report provides a complete analysis of the Global Pediatric (Infants) Vaccine Market and their projections for the upcoming years, Growth Drivers, Challenges, and Disease wise number of reported cases. © Renub Research Page 3 of 7 www.renub.com

  4. Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease (Influenza, MMR, Pneumonia, Meningitis, Hepatitis, Tap, Hib, Polio, etc) & Companies By Disease • Influenza • MMR (Measles, Mumps, and Rubella) • Pneumonia • Meningitis • Hepatitis • Tap (Diphtheria, Tetanus, Pertussis) • Haemophilus influenzae type B • Polio • Rotavirus • Varicella • Combination Vaccine Key Companies Covered in the Report • GlaxoSmithKline • Merck • Sanofi • Pfizer Key Topics Covered 1. Research Findings 2. Pediatric (Infant) Vaccines Market (2011 – 2024) 3. Market & Numbers Share – Pediatric Vaccines 3.1 Pediatric Vaccine Market Share 3.2 Pediatric Vaccinated Population Share 3.3 Pediatric Doses of Vaccines Administered Share 3.4 Vaccine Companies Market Share 4. Pediatric Vaccinated Numbers 5. Pediatric Doses of Vaccines Administered 6. Disease wise – Pediatric (Infants) Vaccines Market (2011 – 2024) 6.1 Influenza 6.2 MMR (Measles, Mumps, and Rubella Vaccine) 6.3 Pneumococcal 6.4 Meningococcal 6.5 Hepatitis 6.6 DTaP © Renub Research Page 4 of 7 www.renub.com

  5. Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease (Influenza, MMR, Pneumonia, Meningitis, Hepatitis, Tap, Hib, Polio, etc) & Companies 6.7 Haemophilus Influenzae Type B (HIB) 6.8 Combos (Combination) 6.9 Polio 6.10 Rotavirus 6.11 Varicella 7. Disease wise – Numbers of Vaccinated Pediatric (Infants) (2011 – 2024) 7.1 Influenza 7.2 MMR 7.3 Pneumococcal 7.4 Meningococcal 7.5 Hepatitis 7.6 DTaP 7.7 Hib (Haemophilus Influenzae Type B) 7.8 Combos (Combination Vaccines) 7.9 Polio 7.10 Rotavirus 7.11 Varicella 8. Disease wise – Doses of Vaccines Administered in Pediatric (Infants) (2011 – 2024) 8.1 Influenza 8.2 MMR 8.3 Pneumococcal 8.4 Meningococcal 8.5 Hepatitis 8.6 DTaP 8.7 Hib (Haemophilus Influenzae Type B) 8.8 Polio 8.9 Rotavirus 8.10 Varicella 9. Disease wise - Immunization Profile 9.1 Immunization Coverage (%) in Infants 9.2 Global Immunization Profile © Renub Research Page 5 of 7 www.renub.com

  6. Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease (Influenza, MMR, Pneumonia, Meningitis, Hepatitis, Tap, Hib, Polio, etc) & Companies 9.3 Regional Immunization Profile 10. Vaccines Key Players Sales (2011 – 2024) 10.1 GlaxoSmithKline, plc.’s Vaccines Sales 10.2 Merck & Co. Vaccines Sales 10.3 Sanofi Pasteur’s Vaccines Sales 10.4 Pfizer, Inc.’s Vaccines Sales 10.5 Global – Other Companies Vaccines Sales 11. Vaccines – Products and Pipeline 11.1 GSK Vaccine Product Pipeline 11.2 Merck Vaccine Product Pipeline 11.3 Sanofi Vaccine Product Pipeline 11.4 Pfizer Vaccine Product Pipeline 12. Top Mergers and Acquisitions in the Vaccine Industry 13. Vaccines and Regulator’s Interventions 13.1 Making and Meeting Standards of Quality and Safety 13.2 Vaccine Funding 14. Vaccine Market Drivers 14.1 Inclusion in National Immunization Schedule 14.2 Growing Immunization Coverage for HPV Vaccines 14.3 Increase in Prevalence of Infectious Diseases 14.4 Global Immunization Vision and Strategy (GIVS) 14.5 GAVI Model Fuelling Vaccine Manufacturers 14.6 Increasing Vaccine Availability in United States 14.7 The Vaccine Safety Data link Project 14.8 The Vaccine Injury Compensation Program 14.9 Transforming of Vaccine Technologies 14.10 Global Vaccine Action Plan by WHO (2011 - 2020) 14.11 Continuous Focus on Effective Communication Strategies 15. Vaccines Market Challenges 15.1 Hurdles to Optimal use of Licensed Vaccines 15.2 Complexity of Vaccine Development & Approval System Thwarts Product Development © Renub Research Page 6 of 7 www.renub.com

  7. Pediatric Vaccine Market, Global Forecast Infants Vaccinated, Vaccines Administered, Immunization, By Disease (Influenza, MMR, Pneumonia, Meningitis, Hepatitis, Tap, Hib, Polio, etc) & Companies 15.3 Shortening the Timeline for Vaccine Development 15.4 Refusal/Resistance to Vaccination 15.5 Vaccine Shortages and Delays 15.6 Obstacles in Vaccine Research & Development 15.7 Barriers to New Entrants in the Vaccines Market Vaccines Market Reports: https://www.renub.com/vaccines-12-c.php Renub Research - North America Renub Research - Asia Rajat Gupta Ankit Mishra 225 Kristie Ln, Roswell C – 86, Sector – 10 Georgia 30076, United States Noida 201301, India Tel: +1-678-302-0700 Tel: +91-120-421-9822 Email: info@renub.com Email: info@renub.com https://www.renub.com/ https://www.renub.com/ © Renub Research Page 7 of 7 www.renub.com

More Related